Encare Competitive Intelligence & Landscape

Encare's vision is to lead the digitalization of medical science, transforming it into best clinical practice for improved quality of care and health economics [encare.net/about-us-encare/].

Encare's core products and services include the ERAS® Interactive Audit System (EIAS) and various specialized protocols covering a wide range of surgeries such as Bariatric, Breast Reconstruction, Cardiac, Colorectal, Gynecology, Head & Neck, Hip & Knee Arthroplasty, Liver, Pancreas, Thoracic-Lung, and Urology protocols [encare.net/]. These offerings are designed to ensure consistent application of ERAS® guidelines, which are proven to improve perioperative care [encare.net/]. The company targets hospitals and healthcare professionals globally who aim to enhance surgical quality and achieve better patient outcomes through data-driven improvement [encare.net/].

While the exact founding year is not explicitly stated, Encare has demonstrated significant growth and international ambition. In September 2022, the company successfully raised SEK 26 million in an issue led by Sciety to accelerate its global expansion and further develop its web-based SaaS-solution [encare.net/news/news-about-encare/encare-has-raised-sek-26-million-to-accelerate-global-expansion/]. The company is led by CEO Rasmus Waller, who brings over 15 years of experience in international healthcare IT business [encare.net/author/rasmus/]. Its management and board of directors, including Hans-Peter Ostler with extensive experience in investment banking and life sciences, underscore its strategic direction and commitment to global operations [encare.net/board-of-directors/].

Encare continues to expand its reach, as evidenced by its goal to achieve global expansion and secure new ERAS® Qualified Centers worldwide [encare.net/news/news-about-encare/encare-has-raised-sek-26-million-to-accelerate-global-expansion/].

The ERAS® Interactive Audit System (EIAS), developed by Encare, is a central component that ensures teams comply with ERAS® protocols, facilitates implementation and retention of best practices, and supports quality improvement through real-time analysis. It also serves as a valuable research tool for audits and clinical trials [https://encare.net/products-and-services/eras-interactive-audit-system-eias/]. While specific pricing plans are not publicly listed, Encare offers a "Book Demo" option [https://encare.net/book-demo/] for potential clients, suggesting a personalized sales approach rather than a fixed, publicly advertised pricing structure. They also highlight an optional feature for automatic EHR data transfer to EIAS, which likely incurs an additional cost [https://encare.net/solution/eras-interactive-audit-system-eias/automatic-data-transfer/].

The ERAS® Implementation Program (EIP) is a comprehensive, 8-10 month training program suitable for entire perioperative teams, integrating the use of the EIAS to empower teams to implement and uphold ERAS® Protocols [https://encare.net/products-and-services/eip-eras-implementation-program/]. Additionally, the ERAS® Flash Audit provides a quick assessment of compliance with core ERAS® elements, helping hospitals identify areas for improvement [https://encare.net/flash-audit/].

Encare emphasizes the financial benefits of ERAS® implementation, offering a calculator to estimate potential cost savings based on surgical specialty, annual surgeries, and average length of stay, with more detailed estimates available upon contact [https://encare.net/calculate-savings-with-eras/]. This indicates a value-based pricing model, where costs are likely tailored to the specific needs and potential savings of each healthcare institution.

While specific job openings are not always publicly detailed, Encare's

Encare's financial model is built on delivering substantial cost savings and improved efficiency for healthcare providers. Hospitals utilizing Encare's platform can realize up to 40% cost savings per patient, primarily by streamlining workflows and optimizing staff time [https://encare.net/]. This financial impact is a core benefit of their digitalized ERAS® protocols, which aim to transform medical science into best clinical practice for better quality of care and health economics [https://encare.net/about-us-encare/]. The company emphasizes that simply "doing ERAS®" is not equivalent to effectively delivering ERAS® to achieve these financial and operational benefits [https://encare.net/results/financial-impact/].

While specific revenue figures and detailed valuations beyond the SEK 26 million funding round are not publicly disclosed, Encare's recognition with the Swecare Export Award 2026 highlights its strong performance and sustainable export growth in the Swedish life science sector [https://encare.net/category/news/news-about-encare/]. This award underscores Encare's ability to combine innovation with international reach, further solidifying its global position in value-based surgery and suggesting a positive trajectory in its financial health. As the sole commercial partner of the ERAS® Society, Encare holds a unique and influential position in the market for perioperative care solutions [https://encare.net/].

Beyond major congresses, Encare engages its audience through informative webinars and online content. Their website features resources like the webinar "From Evidence to Results: How ERAS® and the ERAS® Interactive Audit System (EIAS) Transform Perioperative Care," which emphasizes the importance of comprehensive ERAS® adherence over isolated interventions [encare.net/video-webinars/from-evidence-to-results-how-eras-and-the-eras-interactive-audit-system-eias-transform-perioperative-care/]. These digital events, often featuring experts like Associate Professor Ulf O. Gustafsson, Chairman of the ERAS® Society, provide valuable insights into optimizing perioperative care and demonstrate Encare's thought leadership in the field [encare.net/author/info_5p30bm5o/].

Encare's participation extends to recognizing excellence within the ERAS® framework, celebrating milestones such as hospitals becoming ERAS® Qualified Centers, like Hospital Británico de Buenos Aires for Colorectal Surgery and Gleneagles Hospital Johor for Knee Arthroplasty [encare.net/]. Furthermore, Encare has received accolades such as the Swecare Export Award 2026, which acknowledges their innovation and global reach in value-based surgery, underscoring their influence and recognition within the life science sector [encare.net/category/news/news-about-encare/]. Through these diverse engagements, Encare continuously reinforces its position as a leader in advancing Enhanced Recovery After Surgery protocols worldwide.